Catalyst Pharmaceuticals (NasdaqCM:CPRX) FY Conference Transcript
Catalyst Pharmaceuticals (NasdaqCM:CPRX) FY Conference September 08, 2025 09:00 AM ET Company ParticipantsRichard Daly - President, CEO & DirectorSteven Miller - Executive VP, COO & Chief Scientific OfficerConference Call ParticipantsAndrew Fein - MD & Senior Healthcare AnalystAndrew FeinGood morning, everyone. I'm Andrew Fine. I'm one of the research analysts at HC Wainwright. Thank you very much for joining us today. I'm happy to be here with Catalyst Pharmaceuticals, one of the great success stories from ...